• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX; SUPRARENAL AORTIC EXTENSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX; SUPRARENAL AORTIC EXTENSION Back to Search Results
Model Number A34-34/C100-O20
Device Problems Stretched (1601); Material Integrity Problem (2978); Separation Problem (4043)
Patient Problem Failure of Implant (1924)
Event Date 12/23/2018
Event Type  Injury  
Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
The patient was initially implanted with a bifurcated stent graft and a suprarenal stent graft extension to treat an abdominal aortic aneurysm (aaa).Approximately five (5) years post initial procedure, a type 1a endoleak was identified.A secondary procedure was completed.The physician elected to implant a non- endolgix stent (medtronic) to treat the reported the event.As of the date of this report, there have been no additional patient sequelae reported.
 
Manufacturer Narrative
The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device was not returned as the device remains implanted therefore no evaluation was completed.At the completion of the clinical assessment, clinical was able to find substantial evidence to support the following reported events of a type 1a endoleak and an additional finding of crown separation.This event is most likely device related due to the crown separation.No additional investigation of this reported event is planned however if additional information pertinent to the incident is obtained, a follow-up report will be submitted.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.Correction: conclusion code: remove code 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
SUPRARENAL AORTIC EXTENSION
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key8265460
MDR Text Key133708311
Report Number2031527-2019-00054
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Recall
Type of Report Initial,Followup
Report Date 12/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2015
Device Model NumberA34-34/C100-O20
Device Lot Number1026333R-009
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/23/2018
Initial Date FDA Received01/21/2019
Supplement Dates Manufacturer Received02/01/2019
Supplement Dates FDA Received03/14/2019
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-0006-2019
Patient Sequence Number1
Treatment
BIFURCATED STENT GRAFT, LOT 1053295-011; BIFURCATED STENT GRAFT, LOT 1053295-011
Patient Outcome(s) Required Intervention;
Patient Age87 YR
-
-